Fennec Pharmaceuticals Inc.FENCNASDAQ
LOADING
|||
R&D Expense Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
448.21%
↑ 431% above average
Average (9y)
84.37%
Historical baseline
Range
High:448.21%
Low:-98.35%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | 448.21% |
| 2023 | -98.35% |
| 2022 | -31.32% |
| 2021 | -3.29% |
| 2020 | -11.02% |
| 2019 | 14.56% |
| 2018 | 158.68% |
| 2017 | 310.17% |
| 2016 | 84.38% |
| 2015 | -28.29% |